Antonio Gutiérrez

29PUBLICATIONS
156CO-AUTHORS
Predictive and prognostic markersHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Comparative language studiesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Mar 14, 2026
Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma.

Marta Lafuente, Ramón Diez-Feijóo, Marta García-Recio

|Mar 14, 2026
Avatrombopag Reduces Platelet Transfusion Requirement in Thrombocytopenia Subsequent to Antineoplastic Therapies in Haematological Patients: The Experience of a Tertiary Centre.

Aser Alonso-Carballo, Marta López, María Jiménez

|Mar 12, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma.

Javier Martin-Broto, Javier Martinez-Trufero, Roberto Diaz-Beveridge

|Dec 15, 2025
Histopathologic Diagnostic Agreement Study in Bone and Soft Tissue Tumors: The SELNET Sarcoma Network Experience.

Alberto Righi, Marco Gambarotti, Rafael Ramos

|Jul 25, 2025
Multiclonal Profiling of FLT3-ITD in AML Using MinION Sequencing: A Tailored Clustering Approach to Enhance Subclonal Detection.

Jordi Martínez-Serra, Aser Alonso-Carballo, Ángel Horrillo

|Jul 16, 2025
Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO.

Antonio Gutierrez, Izaskun Zeberio, Francisco Javier Peñalver

Pageof 5

Frequent Collaborators

6 joint publications

Leyre Bento

6 joint publications

Javier Martin-Broto

5 joint publications

Antonio Salar

5 joint publications

Nadia Hindi